SCHEMBL6312837

SCHEMBL6312837

Cc1cnc(C#Cc2ccccc2)s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 12/20 0.50
APP P05067 1/20 0.44
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
TP53 P04637 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
CYP2C19 P33261 1/20 0.41
THPO P40225 1/20 0.41
KMT2A Q03164 1/20 0.41
GRIN2B Q13224 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12599210 0.85 GRM5 (0.48) GRM5ALDH1A1KMT2AKDR
SCHEMBL14886273 0.82 NOS1 (0.34) GRM5APPNPC1RAB9ASMN1; SMN2
SCHEMBL1657055 0.75 GRM5 (0.61) GRM5NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL1657093 0.75 GRM5 (0.45) GRM5APPLMNA
SCHEMBL12461693 0.74
SCHEMBL1657080 0.74 GRM5 (0.64) GRM5APPKDM4E
SCHEMBL15692583 0.74 GRM5 (0.45) GRM5APP
SCHEMBL1663726 0.74 GRM5 (0.47) GRM5APP
SCHEMBL1657374 0.74 GRM5 (0.50) GRM5APPKDM4EALDH1A1
SCHEMBL1657995 0.74 GRM5 (0.45) GRM5APPALDH1A1CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6956049-B1 Methods of modulating processes mediated by excitatory amino acid receptors MERCK & CO., INC. (US) 2005-10-18 US disclosed
EP-1531155-A1 Asymmetrical linear organic oligomers H.C. Starck GmbH (DE) 2005-05-18 EP disclosed
EP-1214303-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF Merck & Co., Inc. (US) 2002-06-19 EP disclosed
WO-2001016121-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF MERCK & CO., INC. (US) 2001-03-08 WO disclosed